Intercept Pharmaceuticals, Inc. (ICPT) Social Stream
INTERCEPT PHARMACEUTICALS INC (ICPT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering INTERCEPT PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 13 | $82 | $18 | $34.357 | $18.66 | 84.12% |
| 2021-11-12 | 11 | $82 | $18 | $32.538 | $18.66 | 74.37% |
| 2021-12-09 | 11 | $82 | $18 | $32.153 | $18.66 | 72.31% |
| 2021-12-22 | 11 | $82 | $16 | $31.923 | $18.66 | 71.08% |
| 2022-01-11 | 11 | $82 | $16 | $30.363 | $18.66 | 62.72% |
| 2022-03-04 | 11 | $82 | $16 | $29.818 | $18.66 | 59.8% |
| 2022-03-11 | 11 | $82 | $16 | $29.454 | $18.66 | 57.85% |
| 2022-05-09 | 10 | $82 | $16 | $28.2 | $18.66 | 51.13% |
| 2022-06-06 | 10 | $82 | $16 | $28.4 | $18.66 | 52.2% |
| 2022-07-21 | 11 | $82 | $16 | $27 | $18.66 | 44.69% |
| 2022-07-27 | 11 | $82 | $16 | $26.818 | $18.66 | 43.72% |
| 2022-08-04 | 10 | $82 | $16 | $26.9 | $18.66 | 44.16% |
| 2022-09-17 | 10 | $82 | $16 | $26.7 | $18.66 | 43.09% |
| 2022-10-03 | 11 | $49 | $14 | $23.2 | $18.66 | 24.33% |
| 2022-11-01 | 11 | $49 | $13.95 | $23.54 | $18.66 | 26.15% |
| 2022-11-04 | 11 | $49 | $13.95 | $23.631 | $18.66 | 26.64% |
| 2023-01-18 | 11 | $49 | $13.95 | $23.45 | $18.66 | 25.67% |
| 2023-02-08 | 11 | $49 | $13.95 | $23.359 | $18.66 | 25.18% |
| 2023-02-27 | 12 | $49 | $13.95 | $22.912 | $18.66 | 22.79% |
| 2023-03-03 | 12 | $49 | $13.95 | $24.079 | $18.66 | 29.04% |
| 2023-03-07 | 12 | $49 | $14 | $25 | $18.66 | 33.98% |
| 2023-04-27 | 12 | $54 | $14 | $25.454 | $18.66 | 36.41% |
| 2023-05-01 | 12 | $54 | $14 | $25.727 | $18.66 | 37.87% |
| 2023-05-05 | 12 | $54 | $14 | $25.4 | $18.66 | 36.12% |
| 2023-05-22 | 12 | $54 | $8 | $24.8 | $18.66 | 32.9% |
| 2023-05-23 | 13 | $54 | $8 | $21.636 | $18.66 | 15.95% |
| 2023-06-06 | 13 | $54 | $8 | $20.272 | $18.66 | 8.64% |
| 2023-06-26 | 13 | $54 | $8 | $20 | $18.66 | 7.18% |
| 2023-06-27 | 13 | $26 | $8 | $14.727 | $18.66 | -21.08% |
| 2023-06-29 | 13 | $26 | $8 | $15.272 | $18.66 | -18.16% |
| 2023-07-28 | 13 | $26 | $10 | $16.181 | $18.66 | -13.29% |
| 2023-08-03 | 13 | $26 | $11 | $16.454 | $18.66 | -11.82% |
| 2023-09-26 | 13 | $26 | $11 | $16.363 | $18.66 | -12.31% |
| 2023-09-27 | 13 | $26 | $12 | $18.454 | $18.66 | -1.1% |
| 2023-10-11 | 13 | $26 | $12 | $18.363 | $18.66 | -1.59% |
| 2023-10-16 | 13 | $26 | $13 | $19 | $18.66 | 1.82% |
The Trend in the Analyst Price Target
Over the past 29 months, ICPT's average price target has gone down $18.05.
ICPT reports an average of 55.25% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-04 | 11 | 49 | 13.95 | 23.631 | 14.87 | 58.92% |
| 2023-02-27 | 12 | 49 | 13.95 | 22.912 | 19.82 | 15.6% |
| 2023-05-05 | 12 | 54 | 14.00 | 25.400 | 16.16 | 57.18% |
| 2023-05-30 | 13 | 54 | 8.00 | 20.272 | 10.77 | 88.23% |
| 2023-09-26 | 13 | 26 | 11.00 | 16.363 | 18.71 | -12.54% |
ICPT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.77 | 2 | 0 | 10 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
Over the past 17 months, ICPT's average broker recommendation rating worsened by 0.17.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ICPT has a lower variance in analysts' estimates than -4379.24% of all US stocks.
- In terms of how INTERCEPT PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 3938.73% of that group.
- INTERCEPT PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 834.9% of Pharmaceutical Products stocks.
- ICPT has a greater average analyst price target than 1630.48% of stocks in the mid market cap category.
Stocks similar to INTERCEPT PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FOLD, CORT, and INVA.
View All Top Stocks by Price Target
Make investment decisions regarding ICPT using the data that counts. Try POWR Ratings for free.